Curis will report its Q3 2026 financial results on November 12, 2026, followed by a conference call at 4:30 p.m. ET to discuss the company's latest clinical progress.
This is a routine scheduling announcement: Curis will report Q3 2026 results on November 12, 2026, with a conference call at 4:30 p.m. ET. No financial figures, guidance or data are disclosed, so the price effect before the actual earnings release is minimal.
On Thursday, November 12, 2026, at 4:00 p.m. ET, with a conference call and webcast at 4:30 p.m. ET.
Curis, Inc. (NASDAQ: CRIS) announced it will release its third quarter 2026 financial and operating results on Thursday, November 12, 2026. The company will host a conference call and webcast at 4:30 p.m. ET to discuss the results and provide updates on its clinical pipeline, including the development of emavusertib.
Curis will report its third quarter 2026 financial and operating results on Thursday, November 12, 2026, at 4:00 p.m. ET.
Investors can join the call by dialing (800)-836-8184 (US) or (646)-357-8785 (international), or by accessing the live webcast via the investor section of the company's website.